Our results revealed that NSC319963 has the most therapeutic potential as a novel scaffold for TNKS inhibition because it inhibits the Wnt/β-catenin signaling pathway and cell proliferation in various CRC cell lines with diverse APC genotypes. Here, TNKS is linked to colorectal carcinoma.